Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:14 PM
Ignite Modification Date:
2025-12-24 @ 5:14 PM
NCT ID:
NCT01240850
Eligibility Criteria:
Inclusion Criteria:
* New diagnosis of idiopathic retroperitoneal fibrosis or chronic periaortitis; written informed consent
Exclusion Criteria:
* Secondary forms of retroperitoneal fibrosis (e.g. drugs, surgery, neoplasms, infections)
* Previous medical therapy for retroperitoneal fibrosis
* Renal failure with creatinine \>2 mg/dl which proved not to be reversible after ureteral decompression
* Hypersensitivity to the study drugs
* Pregnancy
* Active infections or malignant neoplasms
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01240850
Study Brief:
Protocol Section:
NCT01240850